Canine Mammary Tumours (CMTs) exploit mitochondrial cholesterol for aggressive reprogramming
Key Points
Canine mammary tumours exhibit aggressive reprogramming through enhanced mitochondrial cholesterol utilization, indicating their unique metabolic adaptations.
Mitochondrial cholesterol's role in driving aggressive tumor behavior was demonstrated through experimental analyses within the tumor microenvironment.
Targeting lipid metabolism pathways could provide new therapeutic strategies for treating canine mammary tumours, potentially improving outcomes.
Highlights the potential for future studies to explore metabolic targeting, paving the way for innovative interventions in veterinary oncology.